Vital Farms Inc’s filing revealed that its EXECUTIVE CHAIRPERSON OHAYER MATTHEW unloaded Company’s shares for reported $0.77 million on Jan 02 ’26. In the deal valued at $30.85 per share,25,000 shares were sold. As a result of this transaction, OHAYER MATTHEW now holds 6,361,190 shares worth roughly $194.59 million.
Then, OHAYER MATTHEW sold 5,000 shares, generating $176,250 in total proceeds. Upon selling the shares at $35.25, the EXECUTIVE CHAIRPERSON now owns 6,386,190 shares.
Before that, Diez-Canseco Russell sold 16,734 shares. Vital Farms Inc shares valued at $586,527 were divested by the PRESIDENT AND CEO at a price of $35.05 per share. As a result of the transaction, Diez-Canseco Russell now holds 649,684 shares, worth roughly $19.87 million.
Needham initiated its Vital Farms Inc [VITL] rating to a Buy in a research note published on December 05, 2025; the price target was $45. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who began to cover the stock in mid November with a ‘”a Buy”‘ rating. Telsey Advisory Group also remained covering VITL and reiterated its “an Outperform” recommendation on August 08, 2025. Mizuho started covering the stock on July 08, 2025. It rated VITL as “an Outperform”.
Price Performance Review of VITL
On Tuesday, Vital Farms Inc [NASDAQ:VITL] saw its stock fall -0.71% to $30.59. Over the last five days, the stock has gained 1.86%. Vital Farms Inc shares have fallen nearly -23.77% since the year began. Nevertheless, the stocks have fallen -4.23% over the past one year.
How much short interest is there in Vital Farms Inc?
A steep rise in short interest was recorded in Vital Farms Inc stocks on 2025-12-31, growing by 1.24 million shares to a total of 10.02 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 8.78 million shares. There was a rise of 12.39%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 06, 2025 when BMO Capital Markets began covering the stock and recommended ‘”an Outperform”‘ rating along with a $44 price target.
